PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Improvements within 1 hour of stroke treatment associated with better outcomes

2010-11-09
(Press-News.org) Patients with stroke who experience improvement within one hour of receiving the clot-dissolving medication tissue plasminogen activator appear more likely to do well three months later, according to a report in the November issue of Archives of Neurology, one of the JAMA/Archives journals.

Only one effective therapy has been approved for acute ischemic stroke (in which blood flow to an area of the brain is blocked or reduced), according to background information in the article. Within 4.5 hours of developing symptoms, patients receive an intravenous (IV) dose of the medication recombinant tissue plasminogen activator, which helps to break up clots in the blood vessels. "However, not all patients respond to IV therapy; failure to respond to IV therapy is usually, but not always, associated with occlusion of large arteries and lack of recanalization [the formation of new blood vessel paths around the obstruction]," the authors write. "Additional IV thrombolysis [clot-dissolving] therapies, such as chemical and/or mechanical intra-arterial therapy, represent a promising approach to obtaining recanalization and better recovery."

Ioan-Paul Muresan, M.D., and colleagues at Assistance Publique—Hôpitaux de Paris, France, analyzed 120 patients with acute ischemic stroke who were treated with IV recombinant tissue plasminogen activator between Nov. 11, 2002, and Dec. 24, 2007. Individuals were classified as having very early neurologic improvement at one hour if they had a National Institute of Health Stroke Scale score of zero at the end of medication administration or if their score had improved five or more points (on a severity scale of zero to 30) compared with the beginning of therapy.

Of the 120 patients, 22 (18.3 percent) had very early neurologic improvement. After three months, 15 of these patients (68.2 percent) had a favorable outcome as assessed by a scale measuring disability following stroke, compared with 29 patients without early improvement (29.6 percent). None of the patients with very early improvement died, compared with 17.3 percent of other patients.

Asymptomatic brain bleeding occurred in two patients with early improvement (9.1 percent) and in 23 patients without early improvement (23.5 percent). Symptomatic brain bleeding occurred in five patients (4.2 percent), none of whom showed early improvement.

"A promising new approach in the treatment of acute ischemic stroke is bridging therapy with a dual approach: IV thrombolysis by recombinant tissue plasminogen activator followed by chemical or mechanical endovascular therapy," the authors write. "Our results suggest that very early neurologic improvement, as determined by a clinical routine tool (National Institutes of Health Stroke Scale) at a patient's bedside, might help to rapidly select patients who will not respond to IV recombinant tissue plasminogen activator but who could be candidates for bridging therapy."

(Arch Neurol. 2010;67[11]:1323-1328. Available pre-embargo to the media at www.jamamedia.org.)

Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

Editorial: Findings Intriguing, but Require Confirmation

"Evidence-based rationale for the treatment of acute ischemic stroke has accumulated during the last 15 years," writes José Biller, M.D., of Loyola University Chicago, in an accompanying editorial. "Intravenous administration of recombinant tissue plasminogen activator remains the most beneficial proven intervention for emergency management of acute ischemic stroke and the only therapy for acute ischemic stroke approved by the Food and Drug Administration."

"Understanding how baseline clinical, biological and imaging variables affect outcome is critical for the subsequent treatment of patients with acute ischemic stroke and future acute stroke clinical trials design."

"Muresan and colleagues' attempt to answer an interesting question suggest that a quick bedside assessment with the National Institute of Health Stroke Scale can predict good response and conversely, that it can predict poor responders so that the treating physician can begin consideration of mechanical interventions intra-arterial therapy or other alternative therapies."

"As pointed out by the authors, this is a single-center study that needs to be reproduced," Dr. Biller concludes. "Clearly, additional studies involving larger populations with a multicenter design are needed to address the significance and clinical utility of the intriguing findings of this carefully conducted study by Muresan and colleagues."

INFORMATION: (Arch Neurol. 2010;67[11]:1306. Available pre-embargo to the media at www.jamamedia.org.)

Editor's Note: Please see the article for additional information, including author contributions and affiliations, financial disclosures, funding and support, etc.

To contact corresponding author Sonia Alamowitch, M.D., e-mail sonia.alamowitch@tnn.aphp.fr. To contact editorial author José Biller, M.D., call Jim Ritter at 708-216-2445 or e-mail jritter@lumc.edu.

For more information, contact JAMA/Archives Media Relations at 312/464-JAMA (5262) or e-mail mediarelations@jama-archives.org.


ELSE PRESS RELEASES FROM THIS DATE:

Vitamins E and C appear to have little effect on age-related cataract

2010-11-09
Long-term, regular use of vitamins E and C has no apparent effect on the risk of age-related cataract in men, according to a report in the November issue of Archives of Ophthalmology, one of the JAMA/Archives journals. "An estimated 20.5 million persons 40 years and older in the United States show some evidence of age-related cataract," the authors write as background information in the article. "Because oxidative damage is a prominent feature of cataracts, one focus of nutrition research has been the link between dietary intake of nutrients with antioxidant potential, ...

Common corneal condition associated with increased eye pressure

2010-11-09
Corneal arcus, a condition in which a ring of lipids builds up around the cornea, appears common among middle-age and older adults and may be associated with elevated eye pressure, according to a report in the November issue of Archives of Ophthalmology, one of the JAMA/Archives journals. Intraocular pressure (the pressure inside the eye) is the only treatable risk factor for glaucoma, the leading cause of irreversible blindness worldwide, according to background information in the article. "The accuracy of intraocular pressure measurement is crucial in the diagnosis ...

New ocean acidification study shows added danger to already struggling coral reefs

New ocean acidification study shows added danger to already struggling coral reefs
2010-11-09
MIAMI - A new study led by scientists at the University of Miami Rosenstiel School of Marine and Atmospheric Science suggests that over the next century recruitment of new corals could drop by 73 percent, as rising CO2 levels turn the oceans more acidic. The research findings reveal a new danger to the already threatened Caribbean and Florida reef Elkhorn corals. "Ocean acidification is widely viewed as an emerging threat to coral reefs," said Rosenstiel School graduate student Rebecca Albright. "Our study is one of the first to document the impacts of ocean acidification ...

Solar-powered device affordable, reliable tool to measure blood pressure

2010-11-09
A new solar-powered device to measure blood pressure may help slow the worldwide increase in cardiovascular disease by providing affordable and reliable blood pressure testing in low income countries, according to research published in Hypertension: Journal of the American Heart Association. The solar powered device — 94 percent in agreement with the standard blood pressure testing method for systolic blood pressure — is in field testing in Uganda and Zambia, Africa. "The incidence of hypertension is rising dramatically in these countries," said Eoin O'Brien, M.D., ...

Low vitamin D while pregnant or breastfeeding may not be associated with multiple sclerosis relapse

2010-11-09
A small study suggests women with multiple sclerosis have lower vitamin D levels during pregnancy and breastfeeding, according to a report posted online today that will appear in the March 2011 print issue of Archives of Neurology, one of the JAMA/Archives journals. However, these vitamin D levels were not associated with a greater risk of multiple sclerosis relapse after childbirth. "During the last decade, low level of vitamin D, a potent immunomodulator, has emerged as an important risk factor for multiple sclerosis (MS) as well as other autoimmune diseases and certain ...

Discovery could reveal secrets of ancient Martian and terrestrial atmospheres

2010-11-09
Chemists at UC San Diego have uncovered a new chemical reaction on tiny particulates in the atmosphere that could allow scientists to gain a glimpse from ancient rocks of what the atmospheres of the Earth and Mars were like hundreds of millions years ago. Their discovery also provides a simple chemical explanation for the unusual carbonate inclusions found in a meteorite from Mars that was once thought by some scientists to be evidence of ancient Martian life. "We never knew before how the atmosphere could be trapped in carbonate," said Mark Thiemens, dean of UC San ...

New research shows genetic test for lung cancer risk prompts smokers to quit

2010-11-09
Philadelphia – November 8, 2010 – New research shows a gene-based test for lung cancer risk assessment motivates smokers to quit or cut down, according to results of a clinical study presented today at the American Association of Cancer Research's Ninth Annual Conference on Frontiers in Cancer Prevention Research. Six months after taking the Respiragene test to identify susceptibility for lung cancer risk, 32% of the randomly recruited smokers in the study had quit smoking altogether and a further 48% had reduced their intake of cigarettes. More than half of the smokers ...

Massachusetts Institute of Technology IDs new cancer drug target

2010-11-09
CAMBRIDGE, Mass. -- Suppressing cancer cells' ability to replicate damaged DNA could dramatically enhance the effectiveness of chemotherapy drugs such as cisplatin, according to a new pair of papers from MIT biologists. In studies of mice, the researchers found that slowing down a specific system for tolerating DNA damage not only prolonged survival but also prevented relapsed tumors from becoming resistant to chemotherapy, and made tumors much less likely to spread to other parts of the body. Two enzymes that play key roles in a cell's response to DNA damage could ...

Louisiana State University Health Sciences Center research shows fish oil component given up to 5 hours after stroke limits brain damage

2010-11-09
New Orleans, LA – Research led by Dr. Nicolas Bazan, Boyd Professor, Villere Chair, and Director of the Neuroscience Center of Excellence at LSU Health Sciences Center, has shown that Docosahexaenoic acid (DHA), a component of fish oil, is a powerful therapeutic agent that can protect brain tissue and promote recovery in an experimental model of acute ischemic stroke, even when treatment is delayed by up to five hours. These findings not only target a new stroke treatment approach, but also provide vital information about the length of the therapeutic window. The NIH-funded ...

Scientists make advance in dementia research

2010-11-09
The preservation of a protein found in particular synapses in the brain plays a key role in protecting against vascular dementia after a stroke, say researchers at King's College London. The study, funded by the Dunhill Medical Trust, is published today in the 9 November issue of Neurology, the medical journal of the American Academy of Neurology. Researchers say the study findings increase understanding of vascular dementia, and highlight a possible target for future diagnoses and treatment of the condition. Professor Paul Francis, King's College London, said: 'Vascular ...

LAST 30 PRESS RELEASES:

Major review highlights latest evidence on real-time test for blood – clotting in childbirth emergencies

Inspired by bacteria’s defense strategies

Research spotlight: Combination therapy shows promise for overcoming treatment resistance in glioblastoma

University of Houston co-leads $25 million NIH-funded grant to study the delay of nearsightedness in children

NRG Oncology PREDICT-RT study completes patient accrual, tests individualized concurrent therapy and radiation for high-risk prostate cancer

Taking aim at nearsightedness in kids before it’s diagnosed

With no prior training, dogs can infer how similar types of toys work, even when they don’t look alike

Three deadliest risk factors of a common liver disease identified in new study

Dogs can extend word meanings to new objects based on function, not appearance

Palaeontology: South American amber deposit ‘abuzz’ with ancient insects

Oral microbes linked to increased risk of pancreatic cancer

Soccer heading does most damage to brain area critical for cognition

US faces rising death toll from wildfire smoke, study finds

Scenario projections of COVID-19 burden in the US, 2024-2025

Disparities by race and ethnicity in percutaneous coronary intervention

Glioblastoma cells “unstick” from their neighbors to become more deadly

Oral bacterial and fungal microbiome and subsequent risk for pancreatic cancer

New light on toxicity of Bluefin tuna

Menopause drug reduces hot flashes by more than 70%, international clinical trial finds

FGF21 muscle hormone associated with slow ALS progression and extended survival

Hitting the right note: The healing power of music therapy in the cardiac ICU

Cardiovascular disease risk rises in Mexico, despite improved cholesterol control

Flexible optical touch sensor simultaneously pinpoints pressure strength and location

Achalasia diagnosis simplified to AI plus X-ray

PolyU scholars pioneer smart and sustainable personal cooling technologies to address global extreme heat

NIH grant aims for childhood vaccine against HIV

Menstrual cycle and long COVID: A relation confirmed

WMO report on global water resources: 2024 was characterized by both extreme drought and intense rainfall

New findings explain how a mutation in a cancer-related gen causes pulmonary fibrosis

Thermal trigger

[Press-News.org] Improvements within 1 hour of stroke treatment associated with better outcomes